Clinical Trial Update: Dexamethasone-implant for the Treatment of RVO [Phase 4]

View source ↗

Summary

Phase 4 trial update showing completion of a study evaluating a dexamethasone intravitreal implant for macular edema due to retinal vein occlusion.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Macular Edema
• Retinal Vein Occlusion

Drugs mentioned

• Ozurdex (dexamethasone intravitreal implant)

Snippet

Sponsor: Ludwig-Maximilians - University of Munich | Conditions: Macular Edema Caused by Retinal Vein Occlusion | Phase 4 | Status: COMPLETED